• Summary:

    Xuan Wang holds a Ph.D. (Dr. sc.) title from ETH Z├╝rich (Institute of Biochemistry) awarded in 2015. She joined the Caflisch group in May 2016 as a postdoctoral researcher.

    Xuan is an experienced and motivated cell biologist and pharmacologist with in vitro and in vivo research experience. Her responsibilities include proof-of-principle studies to explore new therapeutic applications for bromodomain compounds discovered in-house, and for compound validation works such as assessing target engagement, toxicity and metabolic stability.


    Dr. Xuan Wang was a member of the Caflisch group from 05/2016 - 02/2019.